Tom Jacobs

1.0k total citations
36 papers, 634 citations indexed

About

Tom Jacobs is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tom Jacobs has authored 36 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 6 papers in Infectious Diseases and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tom Jacobs's work include Pharmacological Effects and Toxicity Studies (7 papers), HIV/AIDS drug development and treatment (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Tom Jacobs is often cited by papers focused on Pharmacological Effects and Toxicity Studies (7 papers), HIV/AIDS drug development and treatment (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Tom Jacobs collaborates with scholars based in United States, Netherlands and United Kingdom. Tom Jacobs's co-authors include Armel Stockis, Maria Laura Sargentini‐Maier, Etienne Pigeolet, Aukje K. Mantel‐Teeuwisse, D. Tytgat, Paul Rolan, Hendrika A. van den Ham, Hanne Bak Pedersen, Jane Robertson and Lisa A. Strycker and has published in prestigious journals such as Nature Biotechnology, Neurology and AIDS.

In The Last Decade

Tom Jacobs

29 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Jacobs United States 9 377 376 205 75 71 36 634
Jeannine M. Conway United States 14 154 0.4× 151 0.4× 12 0.1× 77 1.0× 4 0.1× 34 464
Dai Xiu-ying China 12 281 0.7× 308 0.8× 38 0.2× 44 0.6× 18 585
Minji Sohn United States 12 81 0.2× 91 0.2× 19 0.1× 45 0.6× 4 0.1× 35 427
Pratap Kumar Kenya 11 39 0.1× 27 0.1× 85 0.4× 103 1.4× 12 0.2× 23 367
Jeffrey V. Tabares United States 9 140 0.4× 161 0.4× 15 0.1× 53 0.7× 18 338
Lisa Wong Australia 13 62 0.2× 104 0.3× 7 0.0× 41 0.5× 6 0.1× 16 439
Eyad A. Qunaibi Jordan 11 44 0.1× 11 0.0× 75 0.4× 33 0.4× 12 0.2× 18 570
Yuhui Zhu United States 15 106 0.3× 41 0.1× 26 0.1× 99 1.3× 2 0.0× 38 724
Núria Siñol Spain 11 34 0.1× 102 0.3× 80 0.4× 91 1.2× 23 411
Richard H. Rubin United States 10 18 0.0× 66 0.2× 16 0.1× 162 2.2× 15 0.2× 13 422

Countries citing papers authored by Tom Jacobs

Since Specialization
Citations

This map shows the geographic impact of Tom Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Jacobs more than expected).

Fields of papers citing papers by Tom Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Jacobs. The network helps show where Tom Jacobs may publish in the future.

Co-authorship network of co-authors of Tom Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Jacobs. A scholar is included among the top collaborators of Tom Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Jacobs. Tom Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Tom, et al.. (2025). Waste and cost assessment of total intravenous anaesthesia in the context of environmental sustainability. European Journal of Anaesthesiology. 42(7). 655–657.
2.
Jacobs, Tom, et al.. (2024). Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV Medicine. 25(7). 805–816. 3 indexed citations
3.
Payne, Helen, et al.. (2024). Dosing, Toxicity and Drug Concentrations for Ganciclovir/Valganciclovir in Preterm and Low Birthweight Infants Treated for Cytomegalovirus. The Pediatric Infectious Disease Journal. 44(4). 319–325. 1 indexed citations
4.
Jacobs, Tom, et al.. (2024). Harnessing synthetic data to address fraud in cross-border payments. Journal of payments strategy & systems. 18(3). 261–261.
5.
Burger, David M., Elise J. Smolders, Tom Jacobs, et al.. (2023). What the Product Label Does Not Tell You About Drug–Drug Interaction Management. The Journal of Clinical Pharmacology. 63(11). 1181–1185. 5 indexed citations
6.
Jacobs, Tom, Sara Domínguez‐Rodríguez, Alfredo Tagarro, et al.. (2023). Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change. JAIDS Journal of Acquired Immune Deficiency Syndromes. 93(1). 42–46. 1 indexed citations
8.
Jacobs, Tom, Koen van Aerde, Angela Colbers, & David M. Burger. (2021). Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure. The Pediatric Infectious Disease Journal. 41(2). 131–132. 2 indexed citations
10.
Vamos, Cheryl A., et al.. (2018). Identifying Implementation Science Characteristics for a Prenatal Oral Health eHealth Application. Health Promotion Practice. 21(2). 246–258. 8 indexed citations
11.
Jacobs, Tom, et al.. (2018). The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study. BMC Public Health. 18(1). 1384–1384. 12 indexed citations
12.
Sargentini‐Maier, Maria Laura, Antoni Sokalski, Pierre Boulanger, Tom Jacobs, & Armel Stockis. (2012). Brivaracetam Disposition in Renal Impairment. The Journal of Clinical Pharmacology. 52(12). 1927–1933. 50 indexed citations
13.
Jacobs, Tom. (2006). PEGging biotech growth. Nature Biotechnology. 24(5). 506–506. 1 indexed citations
14.
Jacobs, Tom. (2006). My worst biotech investment. Nature Biotechnology. 24(4). 401–401. 1 indexed citations
15.
Jacobs, Tom. (2005). Trials and error. Nature Biotechnology. 23(12). 1481–1481. 2 indexed citations
16.
Jacobs, Tom. (2005). Diversify to multiply. Nature Biotechnology. 23(4). 419–419. 2 indexed citations
17.
Jacobs, Tom. (2005). Great company, bad stock. Nature Biotechnology. 23(2). 173–173.
18.
Jacobs, Tom. (2003). Splurge or merge?. Nature Biotechnology. 21(5). 485–485. 1 indexed citations
19.
Jacobs, Tom. (2003). Let the chips fall where they may. Nature Biotechnology. 21(2). 129–129. 1 indexed citations
20.
Jacobs, Tom. (2002). Just mad about mAbs. Nature Biotechnology. 20(9). 869–869.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026